PART3: untreated CLL

Clinical trials for PART3: untreated CLL explained in plain language.

Never miss a new study

Get alerted when new PART3: untreated CLL trials appear

Sign up with your email to follow new studies for PART3: untreated CLL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

New pill shows promise for Hard-to-Treat blood cancers in japanese patients

Disease control Completed

This study tests a drug called acalabrutinib in Japanese adults with advanced B-cell blood cancers (like leukemia and lymphoma). The goal is to see if it is safe and helps control the cancer. Participants take the drug daily, and researchers monitor side effects and how well the …

Matched conditions: PART3: UNTREATED CLL

Phase 1 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Jul 01, 2026 00:00 UTC

PART3: untreated CLL

Get alerted when new PART3: untreated CLL trials appear

New pill shows promise for Hard-to-Treat blood cancers in japanese patients